Clinical Research Directory
Browse clinical research sites, groups, and studies.
Embolization of Middle Meningeal Artery for Subdural Hematoma in Canada (EMMA Can)
Sponsor: University of Manitoba
Summary
EMMA-Can is a prospective cohort study to assess the safety and effectiveness of MMA-embolization for the treatment of CSDH. Hypothesis- EMMA reduces the recurrence rate of CSDH with or without concomitant surgical evacuation.
Official title: Embolization of Middle Meningeal Artery for Subdural Hematoma in Canada -EMMA-Can
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
1000
Start Date
2021-05-01
Completion Date
2029-12-31
Last Updated
2026-02-03
Healthy Volunteers
No
Conditions
Interventions
Embolization of the middle meningeal artery
embolization of the middle meningeal artery with an embolic agent (Microparticles, liquid embolic agents, SwiftPAC coils or others).
Locations (1)
Health Sciences centre
Winnipeg MB, Manitoba, Canada